NCT02161237View on ClinicalTrials.gov

Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

June 26, 2014

Primary Completion Date

December 22, 2016

Study Completion Date

December 22, 2016

Conditions
Kidney Transplantation
Interventions
DRUG

Advagraf®

oral

Trial Locations (2)

Unknown

Seoul

Taipei

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY